From rare disease diagnostics for individual patients to nationwide newborn screening programs, Breda Genetics delivers clinical-grade genomics through diagnostic services, sequencing capacity, ultra-fast workflows and direct scientific collaboration.
Clinical-grade diagnostics.
WES, WGS and panels
with medical reporting
and expert interpretation.
High-quality sequencing
for laboratories with
in-house bioinformatics
and interpretation.
3-day exomes
for time-critical cases
requiring confident
clinical decisions.
Scalable genomic workflows
supporting regional and
national newborn screening
programs.
When rare disease diagnostics require end-to-end workflows with expert clinical reporting.
→ Explore Laboratory Services
→ Read our Industrial Insight: “Where Do I Send It?”
When demand grows faster than your laboratory can scale.
When every day matters for clinical management.
Built on experience from over 4,000 newborn exomes in real-world screening programs.
Many collaborations begin with a single patient or a single sample.
When trust grows, projects often grow with it.
Clinical sequencing
and diagnostic report.
From sample receipt
to final delivery.
NGS sequencing
without medical reporting.
Receive FASTQ files.
Run your own analysis.
3-day exome
for critical
timelines.
FASTQ in 3 days
Report in 5 days.
Newborn screening
at population
scale.
Scalable workflows
for thousands a year